Literature DB >> 10816550

Characterization of an anticryptococcal protein isolated from human serum.

S Sridhar1, M Ahluwalia, E Brummer, D A Stevens.   

Abstract

Human serum at low concentrations inhibits the growth of Cryptococcus neoformans in vitro. Fractionation of serum yielded a purified inhibitory protein with a molecular mass of approximately 81.8 kDa, a pI of approximately 6.2, and an amino acid sequence that matched that of human transferrin. The inhibitory activity and that of apotransferrin and 5% human serum were reversed by 10 microM freshly prepared FeCl(3).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816550      PMCID: PMC97681          DOI: 10.1128/IAI.68.6.3787-3791.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Cryptococcosis; a review with special reference to apparent association with Hodgkin's disease.

Authors:  B R GENDEL; M ENDE; S L NORMAN
Journal:  Am J Med       Date:  1950-09       Impact factor: 4.965

2.  Factors affecting serum inhibited growth of Candida albicans and Cryptococcus neoformans.

Authors:  A T Hendry; A Bakerspigel
Journal:  Sabouraudia       Date:  1969-10

3.  The relationship of transferrin and iron to serum inhibition of Candida albicans.

Authors:  N B Esterly; S R Brammer; R G Crounse
Journal:  J Invest Dermatol       Date:  1967-11       Impact factor: 8.551

4.  Study of the role of iron in the anticryptococcal activity of human serum and fluconazole.

Authors:  D D Grover; E Brummer; D A Stevens
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

5.  Ferric iron reduction by Cryptococcus neoformans.

Authors:  K J Nyhus; A T Wilborn; E S Jacobson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Ferrous iron uptake in Cryptococcus neoformans.

Authors:  E S Jacobson; A P Goodner; K J Nyhus
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Antifungal activity of transferrin.

Authors:  A Shiraishi; T Arai
Journal:  Sabouraudia       Date:  1979-03

8.  Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity.

Authors:  F Nassar; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more
  7 in total

1.  Serum stimulates growth of and proteinase secretion by Aspergillus fumigatus.

Authors:  Anna H T Gifford; Jodine R Klippenstein; Margo M Moore
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis.

Authors:  Anthony Lee; Dena L Toffaletti; Jennifer Tenor; Erik J Soderblom; J Will Thompson; M Arthur Moseley; Michael Price; John R Perfect
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

3.  Molecular cloning and expression analysis of Megalobrama amblycephala transferrin gene and effects of exposure to iron and infection with Aeromonas hydrophila.

Authors:  Tao Teng; Bingwen Xi; Jun Xie; Kai Chen; Pao Xu; Liangkun Pan
Journal:  Fish Physiol Biochem       Date:  2017-02-24       Impact factor: 2.794

Review 4.  Transferrin-mediated iron sequestration as a novel therapy for bacterial and fungal infections.

Authors:  Kevin W Bruhn; Brad Spellberg
Journal:  Curr Opin Microbiol       Date:  2015-08-09       Impact factor: 7.934

Review 5.  Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans.

Authors:  Mélissa Caza; James W Kronstad
Journal:  Front Cell Infect Microbiol       Date:  2013-11-19       Impact factor: 5.293

6.  Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen.

Authors:  Felipe H Santiago-Tirado; Michael D Onken; John A Cooper; Robyn S Klein; Tamara L Doering
Journal:  mBio       Date:  2017-01-31       Impact factor: 7.867

7.  Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague.

Authors:  Ayelet Zauberman; Yaron Vagima; Avital Tidhar; Moshe Aftalion; David Gur; Shahar Rotem; Theodor Chitlaru; Yinon Levy; Emanuelle Mamroud
Journal:  Front Cell Infect Microbiol       Date:  2017-06-21       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.